Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for LGND

Stock NameLigand Pharmaceuticals Incorporated
TickerLGND(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS53220K5048
LEI5493008K7TB0IKP37H79

Show aggregate LGND holdings

News associated with LGND

Fidelity MSCI Health Care Index ETF -- Insider Buying Index Registering 19.3%
A look at the weighted underlying holdings of the Fidelity MSCI Health Care Index ETF (Symbol: FHLC) shows an impressive 19.3% of holdings on a weighted basis have experienced insider buying within the past six months. Illumina Inc (Symbol: ILMN), which makes up 0.27% of the F - 2025-09-09 10:54:08
Ligand Pharmaceuticals (NASDAQ:LGND) Given New $190.00 Price Target at Oppenheimer
Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report) had its price objective upped by Oppenheimer from $167.00 to $190.00 in a report released on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the biotechnology company’s stock. Oppenheimer’s target price points to a potential upside of 13.27% from the stock’s current price. A number of […] - 2025-09-05 05:03:20
Ligand Pharmaceuticals (NASDAQ:LGND) Sets New 52-Week High After Analyst Upgrade
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Thursday after Oppenheimer raised their price target on the stock from $167.00 to $190.00. Oppenheimer currently has an outperform rating on the stock. Ligand Pharmaceuticals traded as high as $166.99 and last traded at $166.54, with […] - 2025-09-04 02:18:55
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives $157.00 Consensus Price Target from Brokerages
Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) have earned a consensus recommendation of “Buy” from the six brokerages that are currently covering the company, Marketbeat reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokerages that have covered the stock in the last […] - 2025-08-27 02:07:03
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Position Lowered by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System decreased its stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 13.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,519 shares of the biotechnology company’s stock after selling 844 shares during the period. Maryland State […] - 2025-08-15 04:50:59
Mutual of America Capital Management LLC Reduces Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Mutual of America Capital Management LLC lowered its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 3.8% in the first quarter, HoldingsChannel.com reports. The fund owned 2,752 shares of the biotechnology company’s stock after selling 110 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Ligand Pharmaceuticals were […] - 2025-08-13 06:48:50
Deutsche Bank AG Sells 1,087 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Deutsche Bank AG decreased its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 0.4% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 287,965 shares of the biotechnology company’s stock after selling 1,087 shares during the quarter. Deutsche Bank AG owned 1.49% […] - 2025-08-13 05:19:03
Ligand Pharmaceuticals (NASDAQ:LGND) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded shares of Ligand Pharmaceuticals (NASDAQ:LGND – Free Report) from a hold rating to a buy rating in a report published on Saturday. Several other analysts have also weighed in on LGND. Royal Bank Of Canada raised their price objective on Ligand Pharmaceuticals from $155.00 to $185.00 and gave the company an […] - 2025-08-12 04:12:53
Ligand Pharma Proposes Private Offering Of $400 Mln Of Sr. Notes
(RTTNews) - Ligand Pharmaceuticals Incorporated (LGND) Monday said it intends to privately offer $400 million of senior notes due 2030. - 2025-08-11 08:37:20
LGND Crosses Above Average Analyst Target
In recent trading, shares of Ligand Pharmaceuticals Inc (Symbol: LGND) have crossed above the average analyst 12-month target price of $144.75, changing hands for $146.32/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: down - 2025-08-08 08:32:29
Insiders Buy the Holdings of TECB ETF
A look at the weighted underlying holdings of the iShares U.S. Tech Breakthrough Multisector ETF (TECB) shows an impressive 14.6% of holdings on a weighted basis have experienced insider buying within the past six months. Ligand Pharmaceuticals Inc (Symbol: LGND), which makes - 2025-07-29 10:45:36
Victory Capital Management Inc. Purchases 13,456 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Victory Capital Management Inc. lifted its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 94.6% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 27,678 shares of the biotechnology company’s stock after acquiring an additional 13,456 shares during the period. Victory Capital Management Inc.’s holdings in Ligand Pharmaceuticals were worth $2,910,000 […] - 2025-07-29 04:23:02
Mutual of America Capital Management LLC Cuts Stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Mutual of America Capital Management LLC cut its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 3.8% during the first quarter, HoldingsChannel.com reports. The fund owned 2,752 shares of the biotechnology company’s stock after selling 110 shares during the period. Mutual of America Capital Management LLC’s holdings in Ligand Pharmaceuticals were […] - 2025-07-24 04:37:00
Arizona State Retirement System Acquires 110 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Arizona State Retirement System raised its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 2.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,407 shares of the biotechnology company’s stock after acquiring an additional 110 shares during the […] - 2025-07-22 07:06:52
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Director Sells $116,750.00 in Stock
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) Director John W. Kozarich sold 934 shares of Ligand Pharmaceuticals stock in a transaction dated Thursday, July 10th. The shares were sold at an average price of $125.00, for a total value of $116,750.00. Following the transaction, the director owned 46,456 shares of the company’s stock, valued […] - 2025-07-14 05:38:47
Oregon Public Employees Retirement Fund Cuts Stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Oregon Public Employees Retirement Fund trimmed its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 2.3% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 4,342 shares of the biotechnology company’s stock after selling 100 shares during the quarter. Oregon Public Employees Retirement […] - 2025-07-09 05:43:24
Allspring Global Investments Holdings LLC Has $10.14 Million Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Allspring Global Investments Holdings LLC decreased its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 3.6% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 96,419 shares of the biotechnology company’s stock after selling 3,643 shares during the quarter. Allspring Global […] - 2025-07-04 05:06:54
Illinois Municipal Retirement Fund Increases Stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Illinois Municipal Retirement Fund increased its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 9.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,725 shares of the biotechnology company’s stock after purchasing an additional 902 […] - 2025-07-02 05:28:54
State of Alaska Department of Revenue Sells 269 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
State of Alaska Department of Revenue decreased its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 2.5% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 10,470 shares of the biotechnology company’s stock after selling 269 shares during the quarter. State of Alaska Department of Revenue’s holdings in Ligand Pharmaceuticals were worth […] - 2025-06-26 04:44:48
10.2% of VTWV Holdings Seeing Recent Insider Buys
A look at the weighted underlying holdings of the Vanguard Russell 2000 Value (VTWV) shows an impressive 10.2% of holdings on a weighted basis have experienced insider buying within the past six months. NBT Bancorp. Inc. (Symbol: NBTB), which makes up 0.17% of the Vanguard Rus - 2025-06-23 10:36:21
Opal Wealth Advisors LLC Purchases Shares of 305 Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Opal Wealth Advisors LLC purchased a new stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The fund purchased 305 shares of the biotechnology company’s stock, valued at approximately $32,000. A number of other hedge funds have […] - 2025-06-17 04:58:58
Handelsbanken Fonder AB Has $700,000 Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Handelsbanken Fonder AB raised its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 13.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,658 shares of the biotechnology company’s stock after buying an additional 800 shares during […] - 2025-06-16 05:01:01
Rhumbline Advisers Trims Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Rhumbline Advisers cut its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 3.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 57,456 shares of the biotechnology company’s stock after selling 1,989 shares during the period. Rhumbline Advisers’ holdings in Ligand Pharmaceuticals […] - 2025-06-13 04:36:56
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives $146.14 Average Price Target from Analysts
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) has earned a consensus recommendation of “Buy” from the seven ratings firms that are currently covering the firm, Marketbeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have updated their coverage on the stock […] - 2025-06-13 02:32:49
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 10,563 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 26.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 50,401 shares of the biotechnology company’s stock after […] - 2025-06-03 05:13:09
Squarepoint Ops LLC Acquires Shares of 16,799 Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Squarepoint Ops LLC acquired a new stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) during the fourth quarter, HoldingsChannel reports. The fund acquired 16,799 shares of the biotechnology company’s stock, valued at approximately $1,800,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Smartleaf Asset Management […] - 2025-05-30 06:09:00
Bank of America Corp DE Has $11.51 Million Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Bank of America Corp DE lifted its stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 2.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 107,439 shares of the biotechnology company’s stock after buying an additional 2,533 shares during the quarter. Bank of America Corp DE’s holdings in Ligand Pharmaceuticals […] - 2025-05-23 04:36:48
Jane Street Group LLC Sells 1,083 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Jane Street Group LLC reduced its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 7.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 13,369 shares of the biotechnology company’s stock after selling 1,083 shares during the quarter. Jane Street Group LLC’s […] - 2025-05-20 04:30:46
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives $146.14 Consensus Target Price from Analysts
Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) have earned an average recommendation of “Buy” from the seven ratings firms that are presently covering the company, MarketBeat reports. Seven analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have updated their coverage on the stock […] - 2025-05-19 02:14:54
The Manufacturers Life Insurance Company Increases Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
The Manufacturers Life Insurance Company increased its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 9.1% during the 4th quarter, Holdings Channel reports. The firm owned 9,373 shares of the biotechnology company’s stock after acquiring an additional 779 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Ligand Pharmaceuticals were worth […] - 2025-05-14 05:10:50

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) LGND holdings

DateNumber of LGND Shares HeldBase Market Value of LGND SharesLocal Market Value of LGND SharesChange in LGND Shares HeldChange in LGND Base ValueCurrent Price per LGND Share HeldPrevious Price per LGND Share Held
2025-11-11 (Tuesday)12,761USD 2,663,221USD 2,663,221
2025-11-10 (Monday)12,761LGND holding increased by 33USD 2,670,750LGND holding increased by 93585USD 2,670,75033USD 93,585 USD 209.29 USD 202.48
2025-11-07 (Friday)12,728USD 2,577,165LGND holding decreased by -73059USD 2,577,1650USD -73,059 USD 202.48 USD 208.22
2025-11-06 (Thursday)12,728LGND holding increased by 33USD 2,650,224LGND holding increased by 233350USD 2,650,22433USD 233,350 USD 208.22 USD 190.38
2025-11-05 (Wednesday)12,695USD 2,416,874LGND holding increased by 11806USD 2,416,8740USD 11,806 USD 190.38 USD 189.45
2025-11-04 (Tuesday)12,695LGND holding increased by 33USD 2,405,068LGND holding decreased by -16413USD 2,405,06833USD -16,413 USD 189.45 USD 191.24
2025-11-03 (Monday)12,662USD 2,421,481LGND holding decreased by -886USD 2,421,4810USD -886 USD 191.24 USD 191.31
2025-10-31 (Friday)12,662USD 2,422,367LGND holding increased by 53813USD 2,422,3670USD 53,813 USD 191.31 USD 187.06
2025-10-30 (Thursday)12,662LGND holding increased by 165USD 2,368,554LGND holding increased by 62608USD 2,368,554165USD 62,608 USD 187.06 USD 184.52
2025-10-29 (Wednesday)12,497LGND holding increased by 66USD 2,305,946LGND holding decreased by -41897USD 2,305,94666USD -41,897 USD 184.52 USD 188.87
2025-10-28 (Tuesday)12,431USD 2,347,843LGND holding decreased by -13674USD 2,347,8430USD -13,674 USD 188.87 USD 189.97
2025-10-27 (Monday)12,431USD 2,361,517LGND holding increased by 37169USD 2,361,5170USD 37,169 USD 189.97 USD 186.98
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LGND by Blackrock for IE00BYXG2H39

Show aggregate share trades of LGND

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY33209.300201.500 202.280USD 6,675 125.04
2025-11-06BUY33211.915186.960 189.456USD 6,252 124.22
2025-11-04BUY33191.455186.280 186.797USD 6,164 123.54
2025-10-30BUY165188.770184.440 184.873USD 30,504 122.50
2025-10-29BUY66184.520191.880 191.144USD 12,616 122.17
2025-10-22SELL-132185.570187.810 187.586USD -24,761 120.41 Loss of -8,867 on sale
2025-10-20BUY66186.740187.760 187.658USD 12,385 119.69
2025-10-17BUY165181.650184.470 184.188USD 30,391 119.35
2025-10-15BUY264183.300185.700 185.460USD 48,961 119.00
2025-10-03BUY224180.990183.810 183.528USD 41,110 118.30
2025-10-02BUY32180.120182.650 182.397USD 5,837 117.96
2025-09-30BUY64177.140177.810 177.743USD 11,376 117.27
2025-09-26BUY64169.720171.550 171.367USD 10,967 116.65
2025-09-25BUY64166.760168.040 167.912USD 10,746 116.36
2025-09-24SELL-486168.960171.900 171.606USD -83,401 116.05 Loss of -26,998 on sale
2025-09-18BUY34169.830170.780 170.685USD 5,803 115.74
2025-09-17BUY102165.410169.230 168.848USD 17,222 115.45
2025-08-20SELL-136155.250156.670 156.528USD -21,288 114.37 Loss of -5,733 on sale
2025-07-30BUY136135.230138.020 137.741USD 18,733 113.14
2025-07-17SELL-68137.570137.840 137.813USD -9,371 111.79 Loss of -1,769 on sale
2025-07-16BUY219129.630130.940 130.809USD 28,647 111.67
2025-07-11SELL-264121.700124.520 124.238USD -32,799 111.42 Loss of -3,385 on sale
2025-07-07BUY99113.760114.860 114.750USD 11,360 111.20
2025-07-02BUY1,815113.660114.680 114.578USD 207,959 111.16
2025-06-20BUY236114.070114.940 114.853USD 27,105 111.14
2025-06-11BUY64115.390116.400 116.299USD 7,443 110.98
2025-06-10BUY64113.420114.950 114.797USD 7,347 110.96
2025-06-04SELL-32103.800103.980 103.962USD -3,327 111.12 Profit of 229 on sale
2025-04-23BUY32105.760111.390 110.827USD 3,546 113.05
2025-04-10SELL-256101.290104.860 104.503USD -26,753 113.87 Profit of 2,397 on sale
2025-04-08SELL-3296.670102.700 102.097USD -3,267 114.18 Profit of 387 on sale
2025-04-07SELL-3299.410102.550 102.236USD -3,272 114.35 Profit of 388 on sale
2025-04-04SELL-16099.570101.150 100.992USD -16,159 114.53 Profit of 2,165 on sale
2025-04-01BUY346104.820107.490 107.223USD 37,099 114.71
2025-03-31SELL-93105.140106.370 106.247USD -9,881 114.83 Profit of 798 on sale
2025-03-21BUY583108.150111.860 111.489USD 64,998 115.28
2025-03-14SELL-480106.190109.250 108.944USD -52,293 115.79 Profit of 3,287 on sale
2025-03-07SELL-60114.830117.100 116.873USD -7,012 116.33 Loss of -33 on sale
2025-03-04SELL-30115.260117.870 117.609USD -3,528 116.36 Loss of -37 on sale
2025-02-25BUY60118.700119.590 119.501USD 7,170 116.33
2025-02-19SELL-30122.000122.620 122.558USD -3,677 116.03 Loss of -196 on sale
2025-02-13BUY90113.930115.990 115.784USD 10,421 115.83
2025-02-12BUY30111.390112.660 112.533USD 3,376 115.92
2025-02-11BUY120112.770114.750 114.552USD 13,746 115.99
2024-12-30SELL-808105.760109.460 109.090USD -88,145 116.27 Profit of 5,798 on sale
2024-11-18SELL-480111.670113.040 112.903USD -54,193 112.97 Profit of 34 on sale
2024-11-08SELL-32121.250127.260 126.659USD -4,053 111.83 Loss of -475 on sale
2024-10-21SELL-32106.780109.410 109.147USD -3,493 0.00 Loss of -3,493 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LGND

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19110,9840159,90369.4%
2025-09-18117,05413,457140,91383.1%
2025-09-1781,0050103,21478.5%
2025-09-1692,6970112,56582.3%
2025-09-1586,01012107,58079.9%
2025-09-1268,2880104,61565.3%
2025-09-1160,50930171,15985.0%
2025-09-1035,59322359,63359.7%
2025-09-09101,28228,400147,52068.7%
2025-09-0832,301042,92875.2%
2025-09-0572,28925,65990,82479.6%
2025-09-0434,07129039,29286.7%
2025-09-0355,9813,08464,95386.2%
2025-09-0233,2981,24754,73260.8%
2025-08-2949,3781,32460,18382.0%
2025-08-2841,1001,12250,66881.1%
2025-08-2742,61253353,75479.3%
2025-08-2630,55416,90544,55668.6%
2025-08-2552,52922657,73691.0%
2025-08-2279,21727,20096,31882.2%
2025-08-2126,4937334,68176.4%
2025-08-2034,99510048,39872.3%
2025-08-1934,4241,31446,47874.1%
2025-08-1857,7734,41284,24668.6%
2025-08-15110,17626,500135,28481.4%
2025-08-1488,17529,505111,16279.3%
2025-08-13106,25111,400149,50271.1%
2025-08-121,046,591263,2751,291,16781.1%
2025-08-11379,9690465,62381.6%
2025-08-0843,7041,58996,37045.4%
2025-08-0796,7527,844131,27573.7%
2025-08-0681,719098,01783.4%
2025-08-0531,9152,29155,50657.5%
2025-08-0427,4753,50042,04065.4%
2025-08-0143,001053,66080.1%
2025-07-3158,147089,22465.2%
2025-07-3044,7846,20772,41061.8%
2025-07-2926,036034,47875.5%
2025-07-2821,43093337,71756.8%
2025-07-2531,56687541,56076.0%
2025-07-2421,5771,18336,71758.8%
2025-07-2341,0436,12351,66379.4%
2025-07-2269,0811,50490,34476.5%
2025-07-21139,7546,798166,00384.2%
2025-07-1877,8828,200132,44158.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.